Pharmaceutical issue in second FTA talks

The United States is working on the issue with the drug pricing based on the positive list system in the ongoing talks of the free trade agreement (FTA) with Korea, likely putting a brake on the nation's health reform.

The Korean government forecast the U.S. will demand a resolution to pricing and regulatory issues in the Korean pharmaceutical industry.

The U.S. Trade Representative has ...